Back
Monopar Therapeutics Stock Price Chart
Sponsored
MNPR
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
65
MNPR
Monopar Therapeutics
Last Price:
21.71
Seasonality Move:
7.43%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.64 | Buy |
20-day SMA: | 6.69 | Buy |
50-day SMA: | 4.51 | Buy |
200-day SMA: | 3.61 | Buy |
8-day EMA: | 11.25 | Buy |
20-day EMA: | 7.63 | Buy |
50-day EMA: | 5.48 | Buy |
200-day EMA: | 4.09 | Buy |
Monopar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.46 | Buy |
Relative Strength Index (14 RSI): | 93.57 | Buy |
Chaikin Money Flow: | 12436621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.85 - 11.69) | Buy |
Bollinger Bands (100): | (0.99 - 7.11) | Buy |
Monopar Therapeutics Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 32.66 while MNPR 8-day simple moving average is 8.64, which is a Buy signal.
- The stock price of MNPR is 32.66 while Monopar Therapeutics 20-day SMA is 6.69, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 4.51 while MNPR share price is 32.66, making it a Buy technically.
- MNPR stock price is 32.66 and Monopar Therapeutics 200-day simple moving average is 3.61, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
114.98M
Price in USD:
32.66
Share Volume:
19.05M
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.37
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 32.66 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 32.66 while MNPR 8-day exponential moving average is 11.25, which is a Buy signal.
- The stock price of MNPR is 32.66 while Monopar Therapeutics 20-day EMA is 7.63, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 5.48 while MNPR share price is 32.66, making it a Buy technically.
- MNPR stock price is 32.66 and Monopar Therapeutics 200-day simple moving average is 4.09, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is 2.46, suggesting Monopar Therapeutics is a Buy
- Monopar Therapeutics Relative Strength Index (RSI) is 93.57, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (0.85 - 11.69), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (0.99 - 7.11), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.